30 May 2014, Brussels – This month has brought significant changes not only to the European Union, but also to EPHA. After six years as Secretary General, I am leaving EPHA to join the World Health Organization (WHO).
Over my time here, I have had the honour of leading a very committed team at the Secretariat in Brussels, and working to serve a phenomenal diverse and inspiring membership that put people and their health and well-being higher up the European agenda. With the support and guidance of the Board and our member organisations, we have been more successful than I could have hoped for and I am sure that this will only continue in future. My successor will still inherit a public health policy challenged by partisan and corporate interests that have little to do with the public good and people’s well-being. Yet I am proud to say that the public health community in Europe is today an influential actor in Europe’s policy-making and has been able to put health and well-being at the heart of European policies, and that EPHA and I personally have been able to contribute to this success.
In order to provide leadership and guidance to the organisation while EPHA is in the process of recruiting a new Secretary General, the EPHA Board has appointed Emma Woodford as Interim Secretary General, and she has stepped down from the Board to take on this role. I would like to thank Emma for taking the responsibility of ensuring continuity and supporting the rest of the team in continuing to deliver a high standard of activity during the changes ahead.
——
Health and the EU economic governance. Read the analysis of EPHA Policy Coordinator for EU Affairs and Governance published in New Europe.
—–
In the run up to the European Elections, I wrote a joint op-ed in the European Voice urging voters to elect a European Parliament that rejects the inclusion of investor state dispute settlement (ISDS) in an EU-US free-trade deal. In the current proposal, secretive dispute-settlement panels would have the right to allow international companies to sue governments for policy measures that could potentially harm their transatlantic trade and their profits. This poses a direct threat to many areas of concern to public health such tobacco control, alcohol, food production and pharmaceuticals. As we argue in the article, this also undermines countries’ legal systems and provides privileged treatment for foreign investors over domestic ones, at the taxpayers’ expense.
In early July we will be publishing a detailed analysis of the potential impact on health of the new European Parliament and Commission. Keep an eye on EPHA’s website for further updates.
Public health, well-being and equity are the key foundations of a prosperous, joyful society. I am certain that EPHA will keep leading the way to make Europe a better place for all. I would like to thank our members, our Board and most of all the EPHA staff for an incredible six years and wish you all the best in future.
Monika Kosińska, EPHA Secretary General
——
——
Read all the online articles from our May 2014 NEWSLETTER
——
——-
Other highlights from previous weeks:
- EU Elections 2014] [What will they mean for health policy for the next five years?
- Medicine shortages in Europe: A disconcerting operational and communication challenge
- 38 leading organisations urge European Council to protect migrant children’s rights
- Keeping Antimicrobial Resistance (AMR) on the radar screen, year-round
- Civil society call for full transparency about the EU-US trade negotiations
—-
EPHA MEMBERS can find the following new information in the members-only section.
—-
